5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(1-ethylpiperidin-4-yl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylsulfonylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(4-fluorophenyl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine

C80H99FN22O5S — CID 167570420

IUPAC5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(1-ethylpiperidin-4-yl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylsulfonylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(4-fluorophenyl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine
SMILESCCN1CCC(N2CC(n3cc(Oc4nc(-c5cc(C)c6c(c5)CN(C)CC6)cnc4N)cn3)C2)CC1.CCS(=O)(=O)N1CCC(n2cc(Oc3nc(-c4cc(C)c5c(c4)CN(C)CC5)cnc3N)cn2)CC1.Cc1cc(-c2cnc(N)c(Oc3cnn(C4CN(c5ccc(F)cc5)C4)c3)n2)cc2c1CCN(C)C2
InChIInChI=1S/C28H38N8O.C27H28FN7O.C25H33N7O3S/c1-4-34-9-5-22(6-10-34)35-16-23(17-35)36-18-24(13-31-36)37-28-27(29)30-14-26(32-28)20-11-19(2)25-7-8-33(3)15-21(25)12-20;1-17-9-18(10-19-13-33(2)8-7-24(17)19)25-12-30-26(29)27(32-25)36-23-11-31-35(16-23)22-14-34(15-22)21-5-3-20(28)4-6-21;1-4-36(33,34)31-9-5-20(6-10-31)32-16-21(13-28-32)35-25-24(26)27-14-23(29-25)18-11-17(2)22-7-8-30(3)15-19(22)12-18/h11-14,18,22-23H,4-10,15-17H2,1-3H3,(H2,29,30);3-6,9-12,16,22H,7-8,13-15H2,1-2H3,(H2,29,30);11-14,16,20H,4-10,15H2,1-3H3,(H2,26,27)
InChIKeyFVIJIRURIXVWRD-UHFFFAOYSA-N
MW1499.89 g/mol
LogP10.56
Rot. Bonds17

About 5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(1-ethylpiperidin-4-yl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylsulfonylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(4-fluorophenyl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine

5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(1-ethylpiperidin-4-yl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylsulfonylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(4-fluorophenyl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine (PubChem CID 167570420) has the molecular formula C80H99FN22O5S and a molecular weight of 1499.89 g/mol. Its IUPAC name is 5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(1-ethylpiperidin-4-yl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylsulfonylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(4-fluorophenyl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine.

Molecular Properties

Compound Name5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(1-ethylpiperidin-4-yl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylsulfonylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(4-fluorophenyl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine
PubChem CID167570420
Molecular FormulaC80H99FN22O5S
Molecular Weight1499.89 g/mol
Exact Mass1498.79
IUPAC Name5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(1-ethylpiperidin-4-yl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylsulfonylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(4-fluorophenyl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine
SMILESCCN1CCC(N2CC(n3cc(Oc4nc(-c5cc(C)c6c(c5)CN(C)CC6)cnc4N)cn3)C2)CC1.CCS(=O)(=O)N1CCC(n2cc(Oc3nc(-c4cc(C)c5c(c4)CN(C)CC5)cnc3N)cn2)CC1.Cc1cc(-c2cnc(N)c(Oc3cnn(C4CN(c5ccc(F)cc5)C4)c3)n2)cc2c1CCN(C)C2
InChIInChI=1S/C28H38N8O.C27H28FN7O.C25H33N7O3S/c1-4-34-9-5-22(6-10-34)35-16-23(17-35)36-18-24(13-31-36)37-28-27(29)30-14-26(32-28)20-11-19(2)25-7-8-33(3)15-21(25)12-20;1-17-9-18(10-19-13-33(2)8-7-24(17)19)25-12-30-26(29)27(32-25)36-23-11-31-35(16-23)22-14-34(15-22)21-5-3-20(28)4-6-21;1-4-36(33,34)31-9-5-20(6-10-31)32-16-21(13-28-32)35-25-24(26)27-14-23(29-25)18-11-17(2)22-7-8-30(3)15-19(22)12-18/h11-14,18,22-23H,4-10,15-17H2,1-3H3,(H2,29,30);3-6,9-12,16,22H,7-8,13-15H2,1-2H3,(H2,29,30);11-14,16,20H,4-10,15H2,1-3H3,(H2,26,27)
InChIKeyFVIJIRURIXVWRD-UHFFFAOYSA-N
XLogP10.56
TPSA293.37 Ų
H-Bond Donors3
H-Bond Acceptors26
Rotatable Bonds17
Heavy Atoms109
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001499.89
LogP ≤ 510.56
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1026

Analyze 5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(1-ethylpiperidin-4-yl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylsulfonylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(4-fluorophenyl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(1-ethylpiperidin-4-yl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylsulfonylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(4-fluorophenyl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine?
The IUPAC name of 5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(1-ethylpiperidin-4-yl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylsulfonylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(4-fluorophenyl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine (CID 167570420) is 5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(1-ethylpiperidin-4-yl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylsulfonylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(4-fluorophenyl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine.
What is the SMILES notation for 5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(1-ethylpiperidin-4-yl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylsulfonylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(4-fluorophenyl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine?
The canonical SMILES for 5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(1-ethylpiperidin-4-yl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylsulfonylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(4-fluorophenyl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine is CCN1CCC(N2CC(n3cc(Oc4nc(-c5cc(C)c6c(c5)CN(C)CC6)cnc4N)cn3)C2)CC1.CCS(=O)(=O)N1CCC(n2cc(Oc3nc(-c4cc(C)c5c(c4)CN(C)CC5)cnc3N)cn2)CC1.Cc1cc(-c2cnc(N)c(Oc3cnn(C4CN(c5ccc(F)cc5)C4)c3)n2)cc2c1CCN(C)C2.
What is the InChIKey of 5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(1-ethylpiperidin-4-yl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylsulfonylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(4-fluorophenyl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine?
The InChIKey is FVIJIRURIXVWRD-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H38N8O.C27H28FN7O.C25H33N7O3S/c1-4-34-9-5-22(6-10-34)35-16-23(17-35)36-18-24(13-31-36)37-28-27(29)30-14-26(32-28)20-11-19(2)25-7-8-33(3)15-21(25)12-20;1-17-9-18(10-19-13-33(2)8-7-24(17)19)25-12-30-26(29)27(32-25)36-23-11-31-35(16-23)22-14-34(15-22)21-5-3-20(28)4-6-21;1-4-36(33,34)31-9-5-20(6-10-31)32-16-21(13-28-32)35-25-24(26)27-14-23(29-25)18-11-17(2)22-7-8-30(3)15-19(22)12-18/h11-14,18,22-23H,4-10,15-17H2,1-3H3,(H2,29,30);3-6,9-12,16,22H,7-8,13-15H2,1-2H3,(H2,29,30);11-14,16,20H,4-10,15H2,1-3H3,(H2,26,27).
What are the key properties of 5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(1-ethylpiperidin-4-yl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylsulfonylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(4-fluorophenyl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine?
5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(1-ethylpiperidin-4-yl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylsulfonylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(4-fluorophenyl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine has a molecular weight of 1499.89 g/mol, XLogP of 10.56, 17 rotatable bonds, 3 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(1-ethylpiperidin-4-yl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-(1-ethylsulfonylpiperidin-4-yl)pyrazol-4-yl]oxypyrazin-2-amine;5-(2,5-dimethyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[1-[1-(4-fluorophenyl)azetidin-3-yl]pyrazol-4-yl]oxypyrazin-2-amine is sourced from PubChem (CID 167570420), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).